Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

MyOnyx System

K-Number: K201014 · 2021-01-13

Decision Date2021-01-13
Product CodeKPI
Advisory CommitteeGU
DecisionSubstantially Equivalent

Device Summary

MyOnyx System is a medical device manufactured by Thought Technology , Ltd.. It received FDA 510(k) clearance on 2021-01-13 under approval number K201014. The device is classified under product code KPI. It was reviewed by the GU advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the MyOnyx System?

MyOnyx System is a medical device that received FDA 510(k) clearance on 2021-01-13. It is manufactured by Thought Technology , Ltd.. The 510(k) number is K201014.

When was MyOnyx System approved by the FDA?

MyOnyx System received FDA 510(k) clearance on 2021-01-13, under approval number K201014.

What company makes MyOnyx System?

MyOnyx System is manufactured by Thought Technology , Ltd..

What is the FDA product code for MyOnyx System?

The FDA product code for MyOnyx System is KPI.

Other Devices by Thought Technology , Ltd.

Related Devices (Code: KPI)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.